Board of Directors of OBS Medical Announces Appointment of Huang Yuhang as New General Manager

In accordance with the relevant provisions of the Company Law of the People's Republic of China and the company's articles of association, the first meeting of the fourth session of the board of directors reviewed and approved the proposal on appointing Mr. Huang Yuhang as the general manager of the company. This appointment takes effect officially on November 3, 2025.

As the new general manager of the company, Mr. Huang Yuhang will be fully responsible for the company's daily operation and management, overall formulate and implement the annual business plan, coordinate the resource allocation of various departments, and be accountable for the company's overall operating performance and the effectiveness of strategic implementation.

Mr. Huang Yuhang, male, Han nationality, Chinese citizen, born in January 2000, holds a Master of International Business degree from the University of Florida, USA, and a Bachelor of Business Administration degree from the University of Nebraska at Omaha, USA.

The board of directors also announced the position change of the former general manager, Mr. Chen Xi. Mr. Chen Xi will no longer serve as the general manager of the company but will continue to hold the position of chairman of the board.

After stepping down as general manager, Mr. Chen Xi will continue to act as the founder and chairman of the company. With his profound industry accumulation, rich management experience and in-depth understanding of the company's development, he will continue to steer the company's future development, coordinate the company's strategic planning and development direction, and provide core guidance and support for the company's major decisions.

The board of directors firmly believes that under the leadership of Mr. Huang Yuhang, the company will comprehensively improve its management level, further consolidate its competitive advantages in core business areas, accelerate technological innovation and market expansion, achieve rapid business growth and leapfrog development, and inject new momentum into the company's high-quality development.

This personnel appointment is an important measure for the company to improve its modern corporate governance structure and strengthen the synergistic effect of strategic leadership and operational execution. It is also a strategic deployment to comply with industry development trends and promote the company to move towards a higher stage, demonstrating the company's firm determination for steady development and continuous improvement.

Talent is the core driving force for enterprise development. In addition to the new general manager taking office, the company will continue to increase efforts in talent introduction and training in the future, providing solid guarantee for the company's technological innovation, business upgrading and strategic expansion.

Board of Directors of Baisheng Medical Co., Ltd.

November 4, 2025